Since January 2025, the regulatory landscape for tobacco and nicotine products in the United States...
The Role of AI and Technology in Accelerating PMTA Reviews
As the U.S. Food and Drug Administration (FDA) seeks to modernise its regulatory processes, technology is emerging as a cornerstone of its strategy, particularly in addressing the long-standing challenges of the premarket tobacco product application...
All articles
Broughton has been engaged in collaborative discussions with the European Directorate for the...
When developing a nicotine product, the choice between freebase nicotine and nicotine salts plays a...
Chromatography is a cornerstone of analytical testing for nicotine products. It allows us to...
In the evolving world of cannabis science, terpenes are stepping out of the background. These...
Our Chief Commercial Officer, Andy Mooney, recently attended the Global Forum on Nicotine (GFN)...
Why MMAD Testing Matters in Inhalation Product Development
Bringing a medical device to market isn’t just about innovation—it’s about precision, compliance,...
The Next Generation Nicotine Delivery (NGND) conference in Miami delivered an energetic and...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
